Free Trial

Andrea Tan Analyst Performance

Analyst at The Goldman Sachs Group

Andrea Tan is a stock analyst at The Goldman Sachs Group, covering 4 publicly traded companies across a range of sectors. Over the past year, Andrea Tan has issued 8 stock ratings, including buy and hold recommendations. While full access to Andrea Tan's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andrea Tan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
8 Last 0 Years
Buy Recommendations
87.50% 7 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy87.5%7 ratings
Hold12.5%1 ratings
Sell0.0%0 ratings

Out of 8 total stock ratings issued by Andrea Tan at The Goldman Sachs Group, the majority (87.5%) have been Buy recommendations, followed by 12.5% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
4 companies

Andrea Tan, an analyst at The Goldman Sachs Group, currently covers 4 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Andrea Tan of The Goldman Sachs Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
4 companies
100.0%

Andrea Tan's Ratings History at The Goldman Sachs Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Insmed, Inc. stock logo
INSM
Insmed
8/13/2025Boost Price Target$122.53$142.00Buy
Insmed, Inc. stock logo
INSM
Insmed
6/11/2025Boost Price Target$97.54$112.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
5/12/2025Lower Price Target$1.93$8.00Buy
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
5/5/2025Boost Price Target$47.61$51.00Neutral
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
4/17/2025Lower Price Target$3.09$16.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/25/2025Lower Price Target$8.05$27.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
3/3/2025Lower Price Target$4.09$19.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/10/2025Lower Price Target$11.88$43.00Buy